Skip to the page

Data / Form D filings / AeroRx Therapeutics, Inc.

AeroRx Therapeutics, Inc.: Form D filing

AeroRx Therapeutics, Inc., a health care company in La Jolla, CA, filed a Form D with the SEC in 2025. The latest, on October 10, 2025, reports $10.4 million sold of a $20.8 million offering to 17 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
11099 NORTH TORREY PINES RD, SUITE 290, La Jolla, CA, 92037
Phone
(858) 869-5635
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2024
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2090778

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Oct 10, 2025New notice$20,751,992$10,376,003$10,375,98917Sep 25, 2025sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Ahmet Tutuncu, M.D., Ph.D.Executive Officer, Director
Tighe ReardonExecutive Officer
Heather Stuart Preston, M.D.Director
Jay B. Lichter, Ph.D.Director
John Stuart Patton, Ph.D.Director
Sanford Madigan, Ph.D.Director

Other health care companies in California that filed recently

Every Form D from the week of Oct 6, 2025 · All recent filings in California · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what AeroRx Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.